PRLD: Prelude Therapeutics Incorporated Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 27.42
Enterprise Value ($M) 14.94
Book Value ($M) 131.46
Book Value / Share 3.11
Price / Book 0.21
NCAV ($M) 91.84
NCAV / Share 2.17
Price / NCAV 0.30

Profitability (mra)
Return on Invested Capital (ROIC) -0.85
Return on Assets (ROA) -0.51
Return on Equity (ROE) -0.60

Liquidity (mrq)
Quick Ratio 5.30
Current Ratio 5.30

Balance Sheet (mrq) ($M)
Current Assets 135.90
Assets 175.51
Liabilities 44.06
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.00
Operating Income -139.71
Net Income -127.17

Cash Flow Statement (mra) ($M)
Cash From Operations -102.89
Cash from Investing 90.19
Cash from Financing -0.12

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Vaddi Krishna 9.50 11.84
02-13 13G/A Flynn James E 0.00 -100.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-10 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-08 84,410 180,518 46.76
2025-04-07 88,484 275,255 32.15
2025-04-04 38,049 178,658 21.30
2025-04-03 31,033 139,692 22.22

(click for more detail)

Similar Companies
PLRX – Pliant Therapeutics, Inc. PMVP – PMV Pharmaceuticals, Inc.
PRAX – Praxis Precision Medicines, Inc. PRTA – Prothena Corporation plc
PTCT – PTC Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io